Bukwang Pharm Co Ltd
KRX:003000

Watchlist Manager
Bukwang Pharm Co Ltd Logo
Bukwang Pharm Co Ltd
KRX:003000
Watchlist
Price: 3 740 KRW -1.06%
Market Cap: 369B KRW

Wall Street
Price Targets

Price Targets Summary
Bukwang Pharm Co Ltd

There are no price targets for Bukwang Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Bukwang Pharm Co Ltd Competitors:
Price Targets
XERS
Xeris Biopharma Holdings Inc
53% Upside
STAR
Strides Pharma Science Ltd
42% Upside
000756
Shandong Xinhua Pharmaceutical Co Ltd
28% Downside
867
China Medical System Holdings Ltd
29% Upside
4887
Sawai Group Holdings Co Ltd
7% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
Bukwang Pharm Co Ltd

For the last 12 years the compound annual growth rate for Bukwang Pharm Co Ltd's revenue is 1%. The projected CAGR for the next 7 years is -1%.

1%
Past Growth
-1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Bukwang Pharm Co Ltd

For the last 12 years the compound annual growth rate for Bukwang Pharm Co Ltd's operating income is -19%. The projected CAGR for the next 7 years is 27%.

-19%
Past Growth
27%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Bukwang Pharm Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Bukwang Pharm Co Ltd's stock price target?
Not Available

Bukwang Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Bukwang Pharm Co Ltd's Revenue forecast?
Projected CAGR
-1%

For the last 12 years the compound annual growth rate for Bukwang Pharm Co Ltd's revenue is 1%. The projected CAGR for the next 7 years is -1%.

What is Bukwang Pharm Co Ltd's Operating Income forecast?
Projected CAGR
27%

For the last 12 years the compound annual growth rate for Bukwang Pharm Co Ltd's operating income is -19%. The projected CAGR for the next 7 years is 27%.

Back to Top